Menu
GWAS Study

Inflammatory and infectious upper respiratory diseases associate with 41 genomic loci and type 2 inflammation.

Saarentaus EC, Karjalainen J, Rämö JT et al.

36653354 PubMed ID
GWAS Study Type
232365 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

SE
Saarentaus EC
KJ
Karjalainen J
RJ
Rämö JT
KT
Kiiskinen T
HA
Havulinna AS
MJ
Mehtonen J
HH
Hautakangas H
RS
Ruotsalainen S
TM
Tamlander M
MN
Mars N
TS
Toppila-Salmi S
PM
Pirinen M
KM
Kurki M
RS
Ripatti S
DM
Daly M
PT
Palotie T
MA
Mäkitie A
PA
Palotie A
Chapter II

Abstract

Summary of the research findings

Inflammatory and infectious upper respiratory diseases (ICD-10: J30-J39), such as diseases of the sinonasal tract, pharynx and larynx, are growing health problems yet their genomic similarity is not known. We analyze genome-wide association to eight upper respiratory diseases (61,195 cases) among 260,405 FinnGen participants, meta-analyzing diseases in four groups based on an underlying genetic correlation structure. Aiming to understand which genetic loci contribute to susceptibility to upper respiratory diseases in general and its subtypes, we detect 41 independent genome-wide significant loci, distinguishing impact on sinonasal or pharyngeal diseases, or both. Fine-mapping implicated non-synonymous variants in nine genes, including three linked to immune-related diseases. Phenome-wide analysis implicated asthma and atopic dermatitis at sinonasal disease loci, and inflammatory bowel diseases and other immune-mediated disorders at pharyngeal disease loci. Upper respiratory diseases also genetically correlated with autoimmune diseases such as rheumatoid arthritis, autoimmune hypothyroidism, and psoriasis. Finally, we associated separate gene pathways in sinonasal and pharyngeal diseases that both contribute to type 2 immunological reaction. We show shared heritability among upper respiratory diseases that extends to several immune-mediated diseases with diverse mechanisms, such as type 2 high inflammation.

33,157 Finnish ancestry cases, 199,208 Finnish ancestry controls

Chapter III

Study Statistics

Key metrics and study information

232365
Total Participants
GWAS
Study Type
Yes
Replicated
1,180 European ancestry cases, 298,846 European ancestry controls
Replication Participants
European
Ancestry
Finland, U.K.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.